---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-062766"
form_type: "8-K"
ticker: "LGVN"
cik: "0001721484"
company_name: "Longeveron Inc."
filed_at: "2024-07-19T23:59:59+00:00"
generated_at: "2026-05-31T19:06:51.435766+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Longeveron raises $9.0M via registered direct offering of 2.24M shares at $4.025; warrants at $3.90

## Summary
- Gross proceeds of approximately $9.0M from sale of 2,236,026 shares and concurrent private placement of warrants for 2,236,026 shares.
- Warrants exercisable immediately at $3.90 per share for 24 months; placement agent fees of 7% plus warrants at $5.0313.
- Net proceeds to fund Lomecel-B clinical programs for HLHS and Alzheimer's disease, regulatory approvals, and working capital.
- Closing expected on July 19, 2024; H.C. Wainwright acted as exclusive placement agent.

## SEC filing metadata
- accession: 0001213900-24-062766
- form_type: 8-K
- ticker: LGVN
- cik: 0001721484
- company_name: Longeveron Inc.
- filed_at: 2024-07-19T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1721484/000121390024062766/0001213900-24-062766-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1721484/000121390024062766/ea0209682-8k_longe.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-062766
- JSON: https://secwatch.observer/filing/0001213900-24-062766.json
- Plain text: https://secwatch.observer/filing/0001213900-24-062766.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.